Immunotherapy in hepatocellular carcinoma: evaluation and management of adverse events associated with atezolizumab plus bevacizumab

by Chiun Hsu, Lorenza Rimassa, Hui-Chuan Sun, Arndt Vogel, Ahmed O. Kaseb
Published 2021-07-01

Real-world efficacy and safety of nab-paclitaxel plus gemcitabine-cisplatin in patients with advanced biliary tract cancers: a multicenter retrospective analysis

by Jaekyung Cheon, Choong-kun Lee, Yun Beom Sang, Hye Jin Choi, Min Hwan Kim, Jun Ho Ji, Kwang Hyun Ko, Chang-Il Kwon, Dae Jung Kim, Sung Hoon Choi, Chan Kim, Beodeul Kang, Hong Jae Chon
Published 2021-08-01

Current treatments and future potential of surufatinib in neuroendocrine tumors (NETs)

by Jianming Xu
Published 2021-08-01

Management of adrenocortical carcinoma: are we making progress?

by Barbara Kiesewetter, Philipp Riss, Christian Scheuba, Peter Mazal, Elisabeth Kretschmer-Chott, Alexander Haug, Markus Raderer
Published 2021-08-01

Apatinib for patients with metastatic biliary tract carcinoma refractory to standard chemotherapy: results from an investigator-initiated, open-label, single-arm, exploratory phase...

by Chenchen Wang, Mingzhu Huang, Qirong Geng, Wenhua Li, Jinjia Chang, Wei Tang, Weijian Guo
Published 2021-08-01

First- or second-generation epidermal growth factor receptor tyrosine kinase inhibitors in a large, real-world cohort of patients with non-small cell lung cancer

by Allen Chung-Cheng Huang, Chi-Hsien Huang, Jia-Shiuan Ju, Tzu-Hsuan Chiu, Pi-Hung Tung, Chin-Chou Wang, Chien-Ying Liu, Fu-Tsai Chung, Yueh-Fu Fang, Yi-Ke Guo, Chih-Hsi Scott Kuo, Cheng-Ta Yang
Published 2021-07-01

IMbrave 151: a randomized phase II trial of atezolizumab combined with bevacizumab and chemotherapy in patients with advanced biliary tract cancer

by Stephen P. Hack, Wendy Verret, Sohail Mulla, Bo Liu, Yulei Wang, Teresa Macarulla, Zhenggang Ren, Anthony B. El-Khoueiry, Andrew X. Zhu
Published 2021-07-01

Is there any room for PD-1 inhibitors in combination with platinum-based chemotherapy as frontline treatment of extensive-stage small cell lung cancer? A systematic review and meta...

by Valerio Gristina, Antonio Galvano, Luisa Castellana, Lavinia Insalaco, Stefania Cusenza, Giuseppa Graceffa, Federica Iacono, Nadia Barraco, Marta Castiglia, Alessandro Perez, Sergio Rizzo, Antonio Russo, Viviana Bazan
Published 2021-07-01

Research progress in immune checkpoint inhibitors for lung cancer in China

by Jiadi Gan, Yihua Huang, Wenfeng Fang, Li Zhang
Published 2021-07-01

Clinical impact of the tumor immune microenvironment in completely resected stage IIIA(N2) non-small cell lung cancer based on an immunological score approach

by Wen Feng, Yuan Li, Lei Shen, Qin Zhang, Xu-Wei Cai, Zheng-Fei Zhu, Meng-Hong Sun, Hai-Quan Chen, Xiao-Long Fu
Published 2021-01-01

FOLFIRINOX relative dose intensity and disease control in advanced pancreatic adenocarcinoma

by Antonin Vary, Loïc Lebellec, Frédéric Di Fiore, Nicolas Penel, Claire Cheymol, Emilia Rad, Farid El Hajbi, Astrid Lièvre, Julien Edeline, André Michel Bimbai, Marie-Cécile Le Deley, Anthony Turpin
Published 2021-07-01

Corrigendum to “Clinical impact of the tumor immune microenvironment in completely resected stage IIIA(N2) non-small cell lung cancer based on an immunoscore approach”

Published 2021-07-01

Oral vinorelbine and cisplatin as first-line therapy for advanced squamous NSCLC patients: a prospective randomized international phase II study (NAVoTrial 03)

by Francesco Grossi, Piotr Jaśkiewicz, Marion Ferreira, Grzegorz Czyżewicz, Dariusz Kowalski, Libero Ciuffreda, Ramon Garcia-Gomez, Salvatore Caruso, Joaquim Bosch-Barrera, Stéphanie Gautier, Christine Ta Thanh Minh, Sébastien Henriet, Gilberto de Castro
Published 2021-07-01

Characterization of circulating tumor cells in early breast cancer patients receiving neoadjuvant chemotherapy

by Anna Jakabova, Zuzana Bielcikova, Eliska Pospisilova, Lubos Petruzelka, Piotr Blasiak, Vladimir Bobek, Katarina Kolostova
Published 2021-07-01

Molecular profiling of soft-tissue sarcomas with FoundationOne Heme identifies potential targets for sarcoma therapy: a single-centre experience

by Susanne Scheipl, Iva Brcic, Tina Moser, Stefan Fischerauer, Jakob Riedl, Marko Bergovec, Maria Smolle, Florian Posch, Armin Gerger, Martin Pichler, Herbert Stoeger, Andreas Leithner, Ellen Heitzer, Bernadette Liegl-Atzwanger, Joanna Szkandera
Published 2021-07-01

What you always wanted to know about gastric MALT-lymphoma: a focus on recent developments

by Markus Raderer, Barbara Kiesewetter
Published 2021-07-01

Corrigendum to “Inflammatory indices and clinical factors in metastatic renal cell carcinoma patients treated with nivolumab: the development of a novel prognostic score (Meet-URO...

Published 2021-07-01

Systematic review of first-line chemotherapy for chemo-naïve extensive-stage small-cell lung cancer: network meta-analysis

by Hao Chen, Nobuyuki Horita, Kentaro Ito, Hideyuki Nagakura, Yu Hara, Nobuaki Kobayash, Masaki Yamamoto, Makoto Kudo, Takeshi Kaneko
Published 2020-10-01

The clinical utility of gene expression assays in breast cancer patients with 0–3 involved lymph nodes

by Mali Barbi, Della Makower, Joseph A. Sparano
Published 2021-08-01

The emerging role of molecular pathology in directing the systemic treatment of endometrial cancer

by Amy Jamieson, Tjalling Bosse, Jessica N. McAlpine
Published 2021-08-01